The TBDA is a collaboration established among biopharmaceutical companies, research organizations and universities to accelerate the discovery and development of novel therapeutic candidates against TB.
Both the partners will work towards bringing Aster Pharmacy’s in-house quality care products to serve the healthcare needs of the local population in KSA
He is a seasoned business leader with a successful track record of over 26 years across local and area roles within the pharmaceutical industry
Roflumilast Tablets had annual sales of US $248 million in the United States according to IQVIA data
For the last ten financial years, the company has posted healthy performance with its revenue from operations growing at 15% CAGR and net profit at 23% CAGR
Valbenazine Capsules had annual sales of US $781 million in the United States according to IQVIA data
In Q2 FY23, the overall performance of the company continued to be strong despite the ongoing geo-political challenges impacting supply chain and costs
This first joint plan on One Health aims to create a framework to integrate systems and capacity so that we can collectively better prevent, predict, detect, and respond to health threats
Yoshindo gets exclusive commercialization rights in Japan for bUstekinumab and bDenosumab developed and manufactured by Biocon Biologics
Cupid Limited has received a purchase order from United Nations Population Fund
Subscribe To Our Newsletter & Stay Updated
